Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 315

1.

Hepatitis B core-related antigen levels after HBeAg seroconversion is associated with the development of hepatocellular carcinoma.

To WP, Mak LY, Wong DK, Fung J, Liu F, Seto WK, Lai CL, Yuen MF.

J Viral Hepat. 2019 Aug 16. doi: 10.1111/jvh.13191. [Epub ahead of print]

PMID:
31418973
2.

Soluble fibrinogen-like protein 2 promotes the growth of hepatocellular carcinoma via attenuating dendritic cell-mediated cytotoxic T cell activity.

Yang M, Zhang Z, Chen J, Xu M, Huang J, Wang M, Li W, Wan X, Yuen MF, Luo X, Xi D, Ning Q.

J Exp Clin Cancer Res. 2019 Aug 13;38(1):351. doi: 10.1186/s13046-019-1326-5.

3.

Targeted genomic profiling identifies frequent deleterious mutations in FAT4 and TP53 genes in HBV-associated hepatocellular carcinoma.

Huang FY, Wong DK, Tsui VW, Seto WK, Mak LY, Cheung TT, Lai KK, Yuen MF.

BMC Cancer. 2019 Aug 8;19(1):789. doi: 10.1186/s12885-019-6002-9.

4.

In Vitro and In Vivo Renoprotective Effects of Telbivudine in Chronic Hepatitis B Patients Receiving Nucleotide Analogue.

Mak LY, Liu SH, Yap DY, Seto WK, Wong DK, Fung J, Chan TM, Lai CL, Yuen MF.

Dig Dis Sci. 2019 Jul 6. doi: 10.1007/s10620-019-05717-0. [Epub ahead of print]

PMID:
31280390
5.

Among Patients with Undetectable Hepatitis B Surface Antigen and Hepatocellular Carcinoma, a High Proportion Has Integration of HBV DNA into Hepatocyte DNA and No Cirrhosis.

Wong DK, Cheng SCY, Lung-Yi Mak L, Wai-Pan To E, Cheuk-Lam Lo R, Cheung TT, Seto WK, Fung J, Man K, Lai CL, Yuen MF.

Clin Gastroenterol Hepatol. 2019 Jun 25. pii: S1542-3565(19)30667-6. doi: 10.1016/j.cgh.2019.06.029. [Epub ahead of print]

PMID:
31252193
6.

Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update.

Sarin SK, Choudhury A, Sharma MK, Maiwall R, Al Mahtab M, Rahman S, Saigal S, Saraf N, Soin AS, Devarbhavi H, Kim DJ, Dhiman RK, Duseja A, Taneja S, Eapen CE, Goel A, Ning Q, Chen T, Ma K, Duan Z, Yu C, Treeprasertsuk S, Hamid SS, Butt AS, Jafri W, Shukla A, Saraswat V, Tan SS, Sood A, Midha V, Goyal O, Ghazinyan H, Arora A, Hu J, Sahu M, Rao PN, Lee GH, Lim SG, Lesmana LA, Lesmana CR, Shah S, Prasad VGM, Payawal DA, Abbas Z, Dokmeci AK, Sollano JD, Carpio G, Shresta A, Lau GK, Fazal Karim M, Shiha G, Gani R, Kalista KF, Yuen MF, Alam S, Khanna R, Sood V, Lal BB, Pamecha V, Jindal A, Rajan V, Arora V, Yokosuka O, Niriella MA, Li H, Qi X, Tanaka A, Mochida S, Chaudhuri DR, Gane E, Win KM, Chen WT, Rela M, Kapoor D, Rastogi A, Kale P, Rastogi A, Sharma CB, Bajpai M, Singh V, Premkumar M, Maharashi S, Olithselvan A, Philips CA, Srivastava A, Yachha SK, Wani ZA, Thapa BR, Saraya A, Shalimar, Kumar A, Wadhawan M, Gupta S, Madan K, Sakhuja P, Vij V, Sharma BC, Garg H, Garg V, Kalal C, Anand L, Vyas T, Mathur RP, Kumar G, Jain P, Pasupuleti SSR, Chawla YK, Chowdhury A, Alam S, Song DS, Yang JM, Yoon EL; APASL ACLF Research Consortium (AARC) for APASL ACLF working Party.

Hepatol Int. 2019 Jul;13(4):353-390. doi: 10.1007/s12072-019-09946-3. Epub 2019 Jun 6.

PMID:
31172417
7.

Plasma Fibronectin Levels Identified via Quantitative Proteomics Profiling Predicts Hepatitis B Surface Antigen Seroclearance in Chronic Hepatitis B.

Liu F, Seto WK, Wong DK, Huang FY, Cheung KS, Mak LY, Sharma R, Zhang S, Fung J, Lai CL, Yuen MF.

J Infect Dis. 2019 Aug 9;220(6):940-950. doi: 10.1093/infdis/jiz223.

PMID:
31056649
8.

Drug-Induced Acute-on-Chronic Liver Failure in Asian Patients.

Devarbhavi H, Choudhury AK, Sharma MK, Maiwall R, Al Mahtab M, Rahman S, Chawla YK, Dhiman RK, Duseja A, Taneja S, Ning Q, Jia JD, Duan Z, Yu C, Eapen CE, Goel A, Tan SS, Hamid SS, Butt AS, Jafri W, Kim DJ, Hu J, Sood A, Midha V, Shukla A, Ghazinian H, Sahu MK, Treeprasertsuk S, Lee GH, Lim SG, Lesmana LA, Lesmana CR, Shah S, Kalal C, Abbas Z, Sollano JD, Prasad VGM, Payawal DA, Dokmeci AK, Rao PN, Shrestha A, Lau GK, Yuen MF, Saraswat VA, Shiha G, Yokosuka O, Kedarisetty CK, Jain P, Bhatia P, Sarin SK; APASL ACLF working party.

Am J Gastroenterol. 2019 Jun;114(6):929-937. doi: 10.14309/ajg.0000000000000201.

PMID:
31021832
9.

Update of the statements on biology and clinical impact of occult hepatitis B virus infection.

Raimondo G, Locarnini S, Pollicino T, Levrero M, Zoulim F, Lok AS; Taormina Workshop on Occult HBV Infection Faculty Members.

J Hepatol. 2019 Aug;71(2):397-408. doi: 10.1016/j.jhep.2019.03.034. Epub 2019 Apr 18. Review.

10.

A global scientific strategy to cure hepatitis B.

Revill PA, Chisari FV, Block JM, Dandri M, Gehring AJ, Guo H, Hu J, Kramvis A, Lampertico P, Janssen HLA, Levrero M, Li W, Liang TJ, Lim SG, Lu F, Penicaud MC, Tavis JE, Thimme R; Members of the ICE-HBV Working Groups; ICE-HBV Stakeholders Group Chairs; ICE-HBV Senior Advisors, Zoulim F.

Lancet Gastroenterol Hepatol. 2019 Jul;4(7):545-558. doi: 10.1016/S2468-1253(19)30119-0. Epub 2019 Apr 10. Erratum in: Lancet Gastroenterol Hepatol. 2019 Jul;4(7):e7.

11.

New Biomarkers of Chronic Hepatitis B.

Mak LY, Seto WK, Fung J, Yuen MF.

Gut Liver. 2019 Mar 5. doi: 10.5009/gnl18425. [Epub ahead of print]

12.

Serum Mac-2 binding protein glycosylation isomer level predicts hepatocellular carcinoma development in E-negative chronic hepatitis B patients.

Mak LY, To WP, Wong DK, Fung J, Liu F, Seto WK, Lai CL, Yuen MF.

World J Gastroenterol. 2019 Mar 21;25(11):1398-1408. doi: 10.3748/wjg.v25.i11.1398.

13.

Association of adipokines with hepatic steatosis and fibrosis in chronic hepatitis B patients on long-term nucleoside analogue.

Mak LY, Lee CH, Cheung KS, Wong DK, Liu F, Hui RW, Fung J, Xu A, Lam KS, Yuen MF, Seto WK.

Liver Int. 2019 Jul;39(7):1217-1225. doi: 10.1111/liv.14104. Epub 2019 Apr 11.

PMID:
30912255
14.

Fibrosis evolution in chronic hepatitis B e antigen-negative patients across a 10-year interval.

Mak LY, Seto WK, Hui RW, Fung J, Wong DK, Lai CL, Yuen MF.

J Viral Hepat. 2019 Jul;26(7):818-827. doi: 10.1111/jvh.13095. Epub 2019 Apr 16.

PMID:
30895682
15.

Serum Mac-2-binding protein glycosylation isomer and risk of hepatocellular carcinoma in entecavir-treated chronic hepatitis B patients.

Mak LY, Ko M, To E, Wong DK, Ma JH, Hui TL, Seto WK, Fung J, Lai CL, Yuen MF.

J Gastroenterol Hepatol. 2019 Feb 20. doi: 10.1111/jgh.14637. [Epub ahead of print]

PMID:
30786068
16.

Correlation of serum Mac-2-binding protein glycosylation isomer (M2BPGi) and liver stiffness in chronic hepatitis B infection.

Mak LY, Wong DK, Seto WK, Ning Q, Cheung KS, Fung J, Lai CL, Yuen MF.

Hepatol Int. 2019 Mar;13(2):148-156. doi: 10.1007/s12072-019-09928-5. Epub 2019 Jan 22.

PMID:
30671807
17.

A Territorywide Prevalence Study on Blood-Borne and Enteric Viral Hepatitis in Hong Kong.

Liu KSH, Seto WK, Lau EHY, Wong DK, Lam YF, Cheung KS, Mak LY, Ko KL, To WP, Law MWK, Wu JT, Lai CL, Yuen MF.

J Infect Dis. 2019 May 24;219(12):1924-1933. doi: 10.1093/infdis/jiz038.

PMID:
30668746
18.

Antiviral Activity, Safety, and Pharmacokinetics of Capsid Assembly Modulator NVR 3-778 in Patients with Chronic HBV Infection.

Yuen MF, Gane EJ, Kim DJ, Weilert F, Yuen Chan HL, Lalezari J, Hwang SG, Nguyen T, Flores O, Hartman G, Liaw S, Lenz O, Kakuda TN, Talloen W, Schwabe C, Klumpp K, Brown N.

Gastroenterology. 2019 Apr;156(5):1392-1403.e7. doi: 10.1053/j.gastro.2018.12.023. Epub 2019 Jan 6.

19.

Novel developments of hepatitis B: treatment goals, agents and monitoring tools.

Mak LY, Seto WK, Fung J, Yuen MF.

Expert Rev Clin Pharmacol. 2019 Feb;12(2):109-120. doi: 10.1080/17512433.2019.1567327. Epub 2019 Jan 21. Review.

PMID:
30621472
20.

Chronic hepatitis B virus infection.

Seto WK, Lo YR, Pawlotsky JM, Yuen MF.

Lancet. 2018 Nov 24;392(10161):2313-2324. doi: 10.1016/S0140-6736(18)31865-8. Review.

PMID:
30496122

Supplemental Content

Loading ...
Support Center